title: ACNP Task Force report on SSRIs and suicidal behavior in youth.
abstract: This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.
authors.affiliation: Columbia University/New York State Psychiatric Institute, New York, NY 10032, USA. jjm@columbia.edu
authors.forename: J John
authors.initials: JJ
authors.lastname: Mann
authors.forename: Graham
authors.initials: G
authors.lastname: Emslie
authors.forename: Ross J
authors.initials: RJ
authors.lastname: Baldessarini
authors.forename: William
authors.initials: W
authors.lastname: Beardslee
authors.forename: Jan A
authors.initials: JA
authors.lastname: Fawcett
authors.forename: Frederick K
authors.initials: FK
authors.lastname: Goodwin
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Leon
authors.forename: Herbert Y
authors.initials: HY
authors.lastname: Meltzer
authors.forename: Neal D
authors.initials: ND
authors.lastname: Ryan
authors.forename: David
authors.initials: D
authors.lastname: Shaffer
authors.forename: Karen D
authors.initials: KD
authors.lastname: Wagner
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013405:Suicide / Q000523:psychology* / Q000706:statistics & numerical data; D013406:Suicide, Attempted / Q000523:psychology; D014481:United States / Q000453:epidemiology
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors